InhaleRx Limited (IRX.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.2 Million AUD | 4755.02% |
| 2022 | 24.8 Thousand AUD | -85.18% |
| 2021 | 167.3 Thousand AUD | 71.6% |
| 2020 | 97.49 Thousand AUD | 109.22% |
| 2019 | 46.59 Thousand AUD | -86.52% |
| 2018 | 345.78 Thousand AUD | -29.9% |
| 2017 | 493.3 Thousand AUD | 49428.61% |
| 2016 | 996.00 AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 60.69 Thousand AUD | -84.15% |
| 2024 Q2 | 60.69 Thousand AUD | 0.0% |
| 2023 Q2 | 219.11 Thousand AUD | 0.0% |
| 2023 Q1 | 219.11 Thousand AUD | 783.54% |
| 2023 FY | 1.2 Million AUD | 4755.02% |
| 2023 Q4 | 382.9 Thousand AUD | 0.0% |
| 2023 Q3 | 382.9 Thousand AUD | 74.75% |
| 2022 FY | 24.8 Thousand AUD | -85.18% |
| 2022 Q4 | 24.8 Thousand AUD | 100.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 Q1 | - AUD | -100.0% |
| 2022 Q3 | 12.4 Thousand AUD | 0.0% |
| 2021 FY | 167.3 Thousand AUD | 71.6% |
| 2021 Q4 | 167.3 Thousand AUD | 87.91% |
| 2021 Q1 | 1836.00 AUD | -90.24% |
| 2021 Q2 | 1835.00 AUD | -0.05% |
| 2021 Q3 | 89.03 Thousand AUD | 4751.99% |
| 2020 FY | 97.49 Thousand AUD | 109.22% |
| 2020 Q4 | 18.8 Thousand AUD | 99.99% |
| 2020 Q1 | 1661.00 AUD | 444.59% |
| 2020 Q2 | 3322.00 AUD | 100.0% |
| 2020 Q3 | 9403.00 AUD | 183.05% |
| 2019 Q2 | 46.29 Thousand AUD | 0.29% |
| 2019 Q1 | 46.16 Thousand AUD | -12.84% |
| 2019 Q3 | 20.32 Thousand AUD | -56.09% |
| 2019 FY | 46.59 Thousand AUD | -86.52% |
| 2019 Q4 | 305.00 AUD | -98.5% |
| 2018 Q1 | 135.69 Thousand AUD | -21.98% |
| 2018 FY | 345.78 Thousand AUD | -29.9% |
| 2018 Q4 | 52.96 Thousand AUD | 0.0% |
| 2018 Q3 | 52.96 Thousand AUD | -60.97% |
| 2018 Q2 | 135.69 Thousand AUD | 0.0% |
| 2017 Q2 | 74.48 Thousand AUD | 0.0% |
| 2017 Q4 | 173.91 Thousand AUD | 0.0% |
| 2017 FY | 493.3 Thousand AUD | 49428.61% |
| 2017 Q1 | 74.48 Thousand AUD | 0.0% |
| 2017 Q3 | 173.91 Thousand AUD | 133.5% |
| 2016 FY | 996.00 AUD | 0.0% |
| 2016 Q2 | 228.00 AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | 67.929% |
| Adherium Limited | 840.98 Thousand AUD | -43.171% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 98.1% |
| Atomo Diagnostics Limited | 4.08 Million AUD | 70.536% |
| Anteris Technologies Ltd | 4.11 Million AUD | 70.712% |
| Control Bionics Limited | 5.12 Million AUD | 76.515% |
| CardieX Limited | 10.9 Million AUD | 88.959% |
| Compumedics Limited | 49.71 Million AUD | 97.578% |
| Cochlear Limited | 2.25 Billion AUD | 99.947% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 92.342% |
| Cyclopharm Limited | 27.13 Million AUD | 95.564% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 89.268% |
| Nova Eye Medical Limited | 23.32 Million AUD | 94.838% |
| HeraMED Limited | 402.89 Thousand AUD | -198.847% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -95.599% |
| ImpediMed Limited | 10.31 Million AUD | 88.332% |
| LBT Innovations Limited | 1.25 Million AUD | 4.136% |
| Micro-X Limited | 15.22 Million AUD | 92.09% |
| Neurotech International Limited | 1963.00 AUD | -61237.035% |
| OncoSil Medical Limited | 1.56 Million AUD | 23.083% |
| PolyNovo Limited | 103.19 Million AUD | 98.833% |
| Respiri Limited | 456.91 Thousand AUD | -163.517% |
| SomnoMed Limited | 91.65 Million AUD | 98.686% |
| Universal Biosensors, Inc. | 6.63 Million AUD | 81.847% |
| Uscom Limited | 3.72 Million AUD | 67.693% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | 86.113% |